ID
32010
Description
Study ID: 105548 Clinical Study ID: HZA105548 Study Title: A double-blind, randomized, placebo-controlled, repeat dose, 2-way crossover drug interaction study to investigate the pharmacokinetic and pharmacodynamic effects following administration of fluticasone furoate/GW642444M Inhalation Powder with ketoconazole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01165125 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol; vilanterol Trade Name: Relvar; vilanterol Study Indication: Asthma
Keywords
Versions (1)
- 10/11/18 10/11/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 11, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Pharmacokinetic and pharmacodynamic effects following administration of fluticasone Inhalation Powder with ketoconazole NCT01165125
Inform Screening, Enrolment, Date of visit, Demography
- StudyEvent: ODM
Description
Inform Enrolment
Alias
- UMLS CUI-1
- C1552002
- UMLS CUI-2
- C4041024
Description
Date of visit
Alias
- UMLS CUI-1
- C1320303
Description
Demography
Alias
- UMLS CUI-1
- C0011298
Description
Patient date of birth
Data type
date
Alias
- UMLS CUI [1]
- C0421451
Description
Gender
Data type
text
Alias
- UMLS CUI [1]
- C0079399
Description
Female of child bearing age
Data type
integer
Alias
- UMLS CUI [1]
- C1960468
Description
Ethnic group
Data type
integer
Alias
- UMLS CUI [1]
- C0015031
Description
Your ancestry or national origin
Data type
integer
Alias
- UMLS CUI [1]
- C3841890
Similar models
Inform Screening, Enrolment, Date of visit, Demography
- StudyEvent: ODM
C4041024 (UMLS CUI-2)
C2985720 (UMLS CUI [2])